Tag: Cobimetinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Cobimetinib

Nathan Guz, Ph.D.

Added to Collection on: 2021-01-05 05:49:21

Tags for this article:

Chemical compounds
Organic compounds
Drugs
Orphan drugs
Exelixis
Genentech
Cobimetinib
Cabozantinib
Aldol
GLOBAL BLOOD THERAPEUTICS
Nathan

Click the tags to see associated articles and topics

View Article Details
Exelixis Enters into Exclusive License Agreement with WuXi Biologics to Support Further ...

Added to Collection on: 2021-03-08 12:56:15

Tags for this article:

Chemical compounds
Life Sciences
Organic compounds
Orphan drugs
Cyclopropanes
Quinolines
Tyrosine kinase inhibitors
Exelixis
Cabozantinib
WuXi Biologics
Biopharmaceutical
Cobimetinib
Exelixis Inc.
2269.HK

Click the tags to see associated articles and topics

View Article Details
[2021] BRAF Kinase Inhibitors Market – Global Exclusive Analysis by Leading Players Overview by ...

Added to Collection on: 2021-04-14 15:00:00

Tags for this article:

Clinical medicine
Chemical compounds
Medicine
Orphan drugs
Cancer treatments
Chemotherapy
Sulfonamides
Benzamides
MEK inhibitor
Vemurafenib
Cobimetinib
Dabrafenib

Click the tags to see associated articles and topics

View Article Details
Exelixis (EXEL) Gets a Hold Rating from Morgan Stanley

Added to Collection on: 2021-04-19 18:45:00

Tags for this article:

Chemical compounds
Organic compounds
Orphan drugs
Drugs
Exelixis
Stock market
TipRanks
Cabozantinib
The Insider
Exel
Stock
Cobimetinib
Exelixis Partners
Exelixis Inc.

Click the tags to see associated articles and topics

View Article Details
EC Approves Additional Indication for Roche's Tecentriq in Lung Cancer Treatment

Added to Collection on: 2021-05-07 17:03:45

Tags for this article:

Cancer treatments
Clinical medicine
Drugs
Orphan drugs
Breakthrough therapy
Chemotherapy
Sulfonamides
Atezolizumab
Antineoplastic drugs
Cobimetinib
Vemurafenib
Targeted therapy
Roche

Click the tags to see associated articles and topics

View Article Details
Regulatory roundup: Roche's Cotellic among cancer drugs with declining approval outlook

Added to Collection on: 2021-08-24 10:29:24

Tags for this article:

Cancer
Drugs
Clinical medicine
Orphan drugs
Breakthrough therapy
Infectious causes of cancer
Lung cancer
Atezolizumab
Cobimetinib
Small-cell carcinoma
Nasopharyngeal carcinoma
Pembrolizumab

Click the tags to see associated articles and topics

View Article Details
Exelixis Inks Third Collaboration Deal in a Week, This Time with Catalent | BioSpace

Added to Collection on: 2022-11-03 15:42:58

Tags for this article:

Chemical compounds
Organic compounds
Exelixis
South San Francisco, California
Antineoplastic drugs
Cabozantinib
Protein kinase inhibitor
Genentech
Catalent
C-Met
Cobimetinib
Monoclonal antibody

Click the tags to see associated articles and topics

View Article Details